For instance, elevated sialylation of cancer cells disrupts the interaction of the NK-activating receptor natural killer group 2D (NKG2D) with ligands on the tumor cells, reducing NK-activating signals derived from tumor cells (19). The gene discussed is KLRK1; the disease is neoplasm.